Stockscreener 앱 받기
0.528
0.94%
-0.005
시간 외 거래:
.53
0.002
+0.38%
전일 마감가:
$0.533
열려 있는:
$0.52
하루 거래량:
461.37K
Relative Volume:
0.26
시가총액:
$20.72M
수익:
$3.04M
순이익/손실:
$-33.97M
주가수익비율:
-0.397
EPS:
-1.33
순현금흐름:
$-52.47M
1주 성능:
-0.08%
1개월 성능:
-12.20%
6개월 성능:
-65.26%
1년 성능:
-78.09%
1일 변동 폭
$0.5157
$0.5442
1주일 범위
$0.5116
$0.5765
52주 변동 폭
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
명칭
Rani Therapeutics Holdings Inc
전화
(408) 457-3700
주소
2051 RINGWOOD AVENUE, SAN JOSE
RANI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.528 | 23.96M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-02 | 개시 | Oppenheimer | Outperform |
| 2024-06-14 | 개시 | Maxim Group | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2022-10-11 | 개시 | UBS | Buy |
| 2022-07-27 | 개시 | H.C. Wainwright | Buy |
| 2022-06-13 | 개시 | Wedbush | Outperform |
모두보기
Rani Therapeutics Holdings Inc 주식(RANI)의 최신 뉴스
Comparing Rani Therapeutics Holdings Inc. in custom built stock radarsDeep Stock Performance and Volatility Analysis - Newser
Will Rani Therapeutics Holdings Inc. rebound enough to break evenDaily Pattern Analysis with Return Forecast - Newser
How Rani Therapeutics Holdings Inc. stock performs during market volatilityBreakout Screener With Alert Based Timing - Newser
Developing predictive dashboards with Rani Therapeutics Holdings Inc. dataShort-Term Price Breakout Signal Analysis - Newser
How institutional ownership impacts Rani Therapeutics Holdings Inc. stockFree Growth Focused Entry Plan Suggestions - Newser
News impact scoring models applied to Rani Therapeutics Holdings Inc.Monthly Long-Term Market Recap and Summary - Newser
Bollinger Bands Show Potential Breakout in Rani Therapeutics Holdings Inc.Low Risk High Return Opportunities Identified - metal.it
Ranking Rani Therapeutics Holdings Inc. among high performing stocks via toolsSmart Risk Entry Zone Technical Analysis - Newser
Automated trading signals detected on Rani Therapeutics Holdings Inc.ROI Focused Setup Screener With Exit Markers - Newser
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionFree Trade Ready Stock Watch for Short Term - Newser
How hedge fund analytics apply to Rani Therapeutics Holdings Inc. stockFree Investment Plan With Growth Optimization - Newser
Strategies to average down on Rani Therapeutics Holdings Inc.Low Risk Trade Timing with Analysis Metrics - Newser
Rani Therapeutics Files $200 Million Mixed Shelf - MarketScreener
Rani (RANI) Q2 Net Loss Improves 16% - Nasdaq
Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewswire
Rani's Oral GLP-1/GLP-2 Obesity Drug Shows Breakthrough Results, Phase 1 Trial Coming in 2025 - Stock Titan
What moving averages say about Rani Therapeutics Holdings Inc.Free Daily Momentum Screener With Alerts - Newser
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Sees Large Growth in Short Interest - Defense World
Visual analytics tools that track Rani Therapeutics Holdings Inc. performanceAsset Safety Selection Using Quantitative Analysis - Newser
What technical models suggest about Rani Therapeutics Holdings Inc.’s comebackMulti-Year Signal Summary and Entry Timing - Newser
Will Rani Therapeutics Holdings Inc. benefit from macro trendsVolume Based Swing Signal Prediction Map - Newser
What is Rani Therapeutics Holdings Inc. company’s growth strategyOutstanding capital returns - Jammu Links News
When is Rani Therapeutics Holdings Inc. stock expected to show significant growthExceptional financial outcomes - Jammu Links News
What is the dividend policy of Rani Therapeutics Holdings Inc. stockMaximize portfolio value with expert tips - Jammu Links News
Is Rani Therapeutics Holdings Inc. stock overvalued or undervaluedCapitalize on market trends with expert guidance - Jammu Links News
What drives Rani Therapeutics Holdings Inc. stock priceMarket-leading growth rates - Jammu Links News
What momentum shifts mean for Rani Therapeutics Holdings Inc.Free Real Time Stock Movement Analysis - newser.com
What institutional investors are buying Rani Therapeutics Holdings Inc. stockAchieve rapid financial growth with expert picks - Jammu Links News
Rani Therapeutics Holdings Inc. Stock Analysis and ForecastInvest confidently with actionable market data - Jammu Links News
How many analysts rate Rani Therapeutics Holdings Inc. as a “Buy”Build wealth steadily with expert advice - Jammu Links News
How does Rani Therapeutics Holdings Inc. generate profit in a changing economyUnlock daily market insights for better decisions - Jammu Links News
What makes Rani Therapeutics Holdings Inc. stock price move sharplyTrading Volume Spike and Reversal Analysis - newser.com
Is Rani Therapeutics Holdings Inc. trending in predictive chart modelsHigh Reward Investment Strategy for Beginners - Newser
Rani Therapeutics Holdings Inc (RANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):